硼替佐米 雷帕霉素分别联合细胞毒药物治疗恶性血液病的研究进展
硼替佐米 雷帕霉素分别联合细胞毒药物治疗恶性血液病的研究进展
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2008年第11期982-984,共3页
Chinese Journal of Practical Internal Medicine
关键词
硼替佐米
雷帕霉素
靶向治疗
恶性血液病
bortezomib
rapamycin
targeted therapy
hematological malignant disease
参考文献18
-
1Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia[ J]. Blood ,2005,106 (4) : 1154 - 1163.
-
2Vink J, Cloos J, Kaspers GJL. Proteasome inhibition as novel treatment strategy in leukemia [ J ]. Br J Haematol, 2006, 134 ( 3 ) : 253 - 262.
-
3Heider U, Kaiser M, Muller C, et al. Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment [ J]. Eur J Haematol,2006,77 (3) :233 - 238.
-
4Rosinol L, Cibeira MT, Uriburu C, et al. Bortezomib:an effective agent in extramedullary disease in multiple myeloma [ J ]. Eur J Haemato1,2006,76 ( 5 ) :905 - 908.
-
5Cortes J,Thomas D,Koller C,et al. Phase I study of bortezomib in refractory or relapsed acute leukemia[ J ]. Clin Cancer Res,2004, 10(4) :3371 -3376.
-
6Pahler JC, Ruiz S, Nieman I, et al. Effects of the proteasome inhibitor bortezomib on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia[ J ]. Clin Canaer Res, 2003,9 ( 12 ) :4570 - 4577.
-
7Atta EC, DeAngels D J, Sirulnik A, et al. Addition of bortezomib (velcade) to AML induction chemotherapy is well tolerated and resuits in a high complete remission rate ( abs 2782 ) [ J ]. Blood, 2005,106 ( 11, part 1 ) :780a.
-
8Orlowski R, Voorhees PM, Garcia RA, et al. Phase Ⅰ trial of the proteasome inhibitor hortezomib and pegytated liposomal doxorubiciri in patients with advanced hematologic malignancies [ J ]. Blood,2005,105 ( 8 ) :3058 - 3065.
-
9林凤茹,姚尔固.雷帕霉素在血液病中的应用[J].国际输血及血液学杂志,2006,29(3):266-269. 被引量：7
-
10Platzbecker U, Haase M, Herbst R, et al. Activity of sirolimus in patients with myelodysplastic syndrome: results of a pilot study [ J ]. Br J Haematol,2005,128 ( 5 ) : 625 - 630.
二级参考文献27
-
1郑克立,王长希,陈立中,唐孝达,范昱,闵志廉,齐隽,黎磊石,刘志红,季曙明.雷帕霉素联合环孢素和皮质类固醇预防肾移植急性排斥反应的临床研究[J].中华器官移植杂志,2004,25(4):240-242. 被引量：10
-
2王征,樊嘉.雷帕霉素在器官移植中的研究进展[J].国外医学（移植与血液净化分册）,2004,2(5):33-35. 被引量：5
-
3王长希,郑克立,赵亮,陈立中,费继光.雷帕霉素联合环孢素和皮质类固醇预防肾移植后急性排斥的临床报告[J].中华器官移植杂志,2004,25(6):376-376. 被引量：1
-
4程元荣.新型强效免疫抑制剂西罗莫司(Sirolimus)的作用机理、药物代谢和临床[J].四川生理科学杂志,2000,22(4):8-9. 被引量：3
-
5Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation, 2001, 72(7): 1181-1190.
-
6Sehgal SN. Rapamune ( RAPA, rapamycin, sirolimus ):Mechanism of action, immunosuppressive effect results from blockade of signal transduction and inhibition cell cycle progression. Clin Biochem, 1998,31(5): 335-340.
-
7Panwalkar A, Verstovsek S, Giles FJ. Mammalian target of rapamycin inhibition as therapy for hematoligic malignancies.Cancer, 2004,100(4):657-666.
-
8Kaplan MJ, Ellis CN, Beta-Csorgo Z, et al. Sytemic toxicity following administration of sirolimus (formly rapamycin ) for psoriasis. Arch Dematol, 1999, 135(5):553-557.
-
9Guba M, Yezhelyev M, Eichhorn ME, et al. Rapamycin induces tumor-specific-thrombosis via tissue factor in the presence of VEGF. Blood, 2005,105(11):4463-4469.
-
10Battaglia M, Stabilini A, and Roncarolo M-G. Rapamycin selectively expands CD4 +/CD25+ FoxP3 + regulatory T cells.Blood, 2005, 105(12): 4743-4748.
共引文献6
-
1扈江伟,任婧,李渤涛,李欲航,陈建琳,胡亮钉,江岷,陈虎.雷帕霉素治疗异基因造血干细胞移植后移植物抗宿主病的初步研究[J].山西医药杂志（上半月）,2009,38(9):796-799. 被引量：2
-
2薛领,缪丽燕.群体药代动力学用于西罗莫司个体化给药研究进展[J].中国临床药理学杂志,2010,26(1):71-74. 被引量：5
-
3张弋,王晓杰,沈中阳.276例次肝移植患者西罗莫司血药浓度监测及临床应用分析[J].中国医院药学杂志,2011,31(24):2041-2044. 被引量：8
-
4董秀娟,焦雪丽,刘萌萌,韩利杰,罗明霞,苏丽,赵晓武.非血缘异基因造血干细胞移植后硬皮病样变1例附文献复习[J].生物医学工程与临床,2013,17(1):61-63. 被引量：1
-
5李旭东,何易,王东宁,胡元,王文文,张祥忠,林东军.雷帕霉素治疗难治性广泛性慢性移植物抗宿主病[J].中国组织工程研究,2013,17(18):3287-3294. 被引量：2
-
6于兰,吴谧,王浩,李翠娟.西罗莫司应用的新进展[J].实用中西医结合临床,2014,14(3):90-92. 被引量：6
-
1宋礼章.免疫抑制剂和细胞毒药物治疗肺疾患[J].哮喘与肺部疾病,1998(2):31-38.
-
2Jose.,PC Mecu.,WJ.免疫抑制和细胞毒药物治疗肺疾患[J].哮喘与肺部疾病,1998(3):53-67.
-
3陈弋弋.地塞米松穴位注射治疗白细胞减少症疗效观察[J].常州实用医学,2013(4):230-231.
-
4李洪毓.系统性红斑狼疮合并颅内感染[J].菏泽医学专科学校学报,2000,12(2):94-95.
-
5史小四（综述）,郭喆（综述）,强烈应（综述）,李儒汉（审校）.常用抗高血压药物的应用进展[J].武警医学,2009,20(1):83-86. 被引量：4
-
6郭茜,马小琴.口服降糖药物的临床评价[J].中国综合临床,2002,18(10):870-871. 被引量：6
-
7舒易超.镁在内科疾病中的临床应用[J].中国综合临床,2001,17(6):409-410.
-
8刘颖,王长来,陈绍良.低分子肝素在急性冠脉综合征中的应用[J].国外医学（心血管疾病分册）,2004,31(2):105-107. 被引量：22
-
9陈亮,唐天驷.强直性脊柱炎早期诊断和系统治疗[J].临床骨科杂志,2002,5(1):27-29. 被引量：23
-
10杨艳华,谢青.慢性丙型肝炎特异性靶向治疗药物的研究进展[J].肝脏,2008,13(1):81-82.
